176 related articles for article (PubMed ID: 31629431)
1. Considerations of germline testing in prostate cancer screening.
Polascik TJ; Orabi H
Can J Urol; 2019 Oct; 26(5 Suppl 2):46-47. PubMed ID: 31629431
[TBL] [Abstract][Full Text] [Related]
2. Cancer Screening and Genetic Testing Recommendations for Relatives of Men Undergoing Prostate Cancer Germline Testing: Implications for Practice.
Giri VN; Hyatt C; Leader A
J Urol; 2020 Dec; 204(6):1116-1118. PubMed ID: 32926644
[No Abstract] [Full Text] [Related]
3. Prostate Cancer Screening in a New Era of Genetics.
Cheng HH; Pritchard CC; Montgomery B; Lin DW; Nelson PS
Clin Genitourin Cancer; 2017 Dec; 15(6):625-628. PubMed ID: 28697982
[TBL] [Abstract][Full Text] [Related]
4. Bringing Prostate Cancer Germline Genetics into Clinical Practice.
Das S; Salami SS; Spratt DE; Kaffenberger SD; Jacobs MF; Morgan TM
J Urol; 2019 Aug; 202(2):223-230. PubMed ID: 30730411
[TBL] [Abstract][Full Text] [Related]
5. Germline testing in those at risk of prostate cancer.
Carroll PR; Witte JS; Parsons JK
Can J Urol; 2019 Oct; 26(5 Suppl 2):31-33. PubMed ID: 31629425
[TBL] [Abstract][Full Text] [Related]
6. Ethnic disparities among men with prostate cancer undergoing germline testing.
Kwon DH; Borno HT; Cheng HH; Zhou AY; Small EJ
Urol Oncol; 2020 Mar; 38(3):80.e1-80.e7. PubMed ID: 31630993
[TBL] [Abstract][Full Text] [Related]
7. Genetically Informed Prostate Cancer Screening.
Arcot R; Morgan TM; Polascik TJ
Urol Clin North Am; 2021 Aug; 48(3):373-386. PubMed ID: 34210492
[TBL] [Abstract][Full Text] [Related]
8. Genetic predisposition to prostate cancer: an update.
Ni Raghallaigh H; Eeles R
Fam Cancer; 2022 Jan; 21(1):101-114. PubMed ID: 33486571
[TBL] [Abstract][Full Text] [Related]
9. Genetics of prostate cancer and its utility in treatment and screening.
Benafif S; Ni Raghallaigh H; McHugh J; Eeles R
Adv Genet; 2021; 108():147-199. PubMed ID: 34844712
[TBL] [Abstract][Full Text] [Related]
10. Considerations of multigene test findings among men with prostate cancer - knowns and unknowns.
AlDubayan SH
Can J Urol; 2019 Oct; 26(5 Suppl 2):14-16. PubMed ID: 31629418
[TBL] [Abstract][Full Text] [Related]
11. Urology perspective on the expanding world of germline testing for prostate cancer.
Cookson MS
Can J Urol; 2019 Oct; 26(5 Suppl 2):5-6. PubMed ID: 31629413
[TBL] [Abstract][Full Text] [Related]
12. Reimagining prostate cancer screening: the IMPACT of germline mutations.
Gandaglia G; Briganti A; Montorsi F
Lancet Oncol; 2021 Nov; 22(11):1491-1492. PubMed ID: 34678157
[No Abstract] [Full Text] [Related]
13. The role of genetic testing in prostate cancer screening, diagnosis, and treatment.
de la Calle CM; Bhanji Y; Pavlovich CP; Isaacs WB
Curr Opin Oncol; 2022 May; 34(3):212-218. PubMed ID: 35238838
[TBL] [Abstract][Full Text] [Related]
14. Clinical Implications of Germline Testing in Newly Diagnosed Prostate Cancer.
Loeb S; Giri VN
Eur Urol Oncol; 2021 Feb; 4(1):1-9. PubMed ID: 33390340
[TBL] [Abstract][Full Text] [Related]
15. Germline and Somatic Mutations in Prostate Cancer for the Clinician.
Cheng HH; Sokolova AO; Schaeffer EM; Small EJ; Higano CS
J Natl Compr Canc Netw; 2019 May; 17(5):515-521. PubMed ID: 31085765
[TBL] [Abstract][Full Text] [Related]
16. Initial outcomes and insights from a novel high-risk prostate cancer screening clinic.
Harper JB; Greenberg SE; Hunt TC; Cooney KA; O'Neil BB
Prostate; 2023 Feb; 83(2):151-157. PubMed ID: 36207779
[TBL] [Abstract][Full Text] [Related]
17. Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer.
Isaacsson Velho P; Silberstein JL; Markowski MC; Luo J; Lotan TL; Isaacs WB; Antonarakis ES
Prostate; 2018 Apr; 78(5):401-407. PubMed ID: 29368341
[TBL] [Abstract][Full Text] [Related]
18. Germline genetic variants in men with prostate cancer and one or more additional cancers.
Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
[TBL] [Abstract][Full Text] [Related]
19. Disparities in germline testing among racial minorities with prostate cancer.
Weise N; Shaya J; Javier-Desloges J; Cheng HH; Madlensky L; McKay RR
Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):403-410. PubMed ID: 34775478
[TBL] [Abstract][Full Text] [Related]
20. When to use germline genetic testing in prostate cancer.
Giri VN
Clin Adv Hematol Oncol; 2022 Feb; 20(2):78-81. PubMed ID: 35120087
[No Abstract] [Full Text] [Related]
[Next] [New Search]
